{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:15:43Z","timestamp":1790806543923,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.eururo.2018.02.026","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:19:02Z","timestamp":1522109942000},"page":"261-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review"],"prefix":"10.1016","volume":"74","author":[{"given":"Netty","family":"Kinsella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bill-Axelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Bratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Van Hemelrijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2018.02.026_bib0575","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2018.02.026_bib0580","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2018.02.026_bib0585","series-title":"Cancer incidence, males, ICD10 C61: prostate, 2008\u20132010","author":"Network","year":"2010"},{"key":"10.1016\/j.eururo.2018.02.026_bib0590","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ije\/dyv305","article-title":"Cohort profile update: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base\u2014a refined prostate cancer trajectory","volume":"45","author":"Van Hemelrijck","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0595","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jama.2015.6036","article-title":"Trends in management for patients with localized prostate cancer, 1990-2013","volume":"314","author":"Cooperberg","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2018.02.026_bib0600","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrurol.2015.313","article-title":"Active surveillance for prostate cancer: a narrative review of clinical guidelines","volume":"13","author":"Bruinsma","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0605","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrurol.2016.45","article-title":"Active surveillance for prostate cancer: current evidence and contemporary state of practice","volume":"13","author":"Tosoian","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0610","doi-asserted-by":"crossref","first-page":"83","DOI":"10.21037\/tau.2017.12.24","article-title":"Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices","volume":"7","author":"Kinsella","year":"2018","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0615","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1470-2045(04)01384-1","article-title":"Active surveillance: towards a new paradigm in the management of early prostate cancer","volume":"5","author":"Parker","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0620","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jamasurg.2017.1586","article-title":"Practice- vs physician-level variation in use of active surveillance for men with low-risk prostate cancer: Implications for collaborative quality improvement","volume":"152","author":"Auffenberg","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.eururo.2018.02.026_bib0625","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jamaoncol.2016.3600","article-title":"Uptake of active surveillance for very-low-risk prostate cancer in Sweden","volume":"3","author":"Loeb","year":"2017","journal-title":"JAMA Oncol"},{"issue":"Suppl 5","key":"10.1016\/j.eururo.2018.02.026_bib0630","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bju.13049","article-title":"The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry","volume":"115","author":"Weerakoon","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib0635","series-title":"Prostate Cancer Statistics","author":"UKCR","year":"2012"},{"key":"10.1016\/j.eururo.2018.02.026_bib0640","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.1111\/bju.12209","article-title":"A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer","volume":"112","author":"Punnen","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items for Systematic Review and Meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.eururo.2018.02.026_bib0650","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0022-5347(05)65174-9","article-title":"Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and\/or clinical progression","volume":"167","author":"Choo","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0655","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s40273-013-0089-7","article-title":"Patient preferences for the treatment of type 2 diabetes: a scoping review","volume":"31","author":"Joy","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.eururo.2018.02.026_bib0660","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"key":"10.1016\/j.eururo.2018.02.026_bib0665","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"Von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0670","series-title":"Methodology for JBI mixed methods systematic reviews. University of Adelaide","author":"The Joanna Briggs Institute","year":"2014"},{"key":"10.1016\/j.eururo.2018.02.026_bib0675","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1258\/jhsrp.2009.008186","article-title":"A Bayesian method for the synthesis of evidence from qualitative and quantitative reports: the example of antiretroviral medication adherence","volume":"14","author":"Voils","year":"2009","journal-title":"J Health Serv Res Policy"},{"key":"10.1016\/j.eururo.2018.02.026_bib0680","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1200\/JCO.2012.42.8466","article-title":"Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer","volume":"30","author":"Aizer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0685","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.eururo.2014.08.024","article-title":"Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer","volume":"67","author":"Womble","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0690","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.juro.2013.05.054","article-title":"Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer","volume":"190","author":"Loeb","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0695","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/j.1464-410X.2010.09833.x","article-title":"Early prostate cancer\u2014which treatment do men prefer and why?","volume":"107","author":"Anandadas","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib0700","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.urology.2015.08.024","article-title":"Factors influencing selection of active surveillance for localized prostate cancer","volume":"86","author":"Liu","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2018.02.026_bib0705","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40615-015-0109-8","article-title":"Racial differences in treatment decision-making for men with clinically localized prostate cancer: a population-based study","volume":"3","author":"Xu","year":"2016","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.eururo.2018.02.026_bib0710","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1158\/1055-9965.EPI-15-1079","article-title":"Treatment preferences for active surveillance versus active treatment among men with low-risk prostate cancer","volume":"25","author":"Taylor","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2018.02.026_bib0715","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eururo.2014.06.010","article-title":"Five-year nationwide follow-up study of active surveillance for prostate cancer","volume":"67","author":"Loeb","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0720","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2018.02.026_bib0725","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.urology.2016.12.063","article-title":"The influence of psychosocial constructs on the adherence to active surveillance for localized prostate cancer in a prospective, population-based cohort","volume":"103","author":"Lang","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2018.02.026_bib0730","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pec.2011.11.009","article-title":"Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance","volume":"87","author":"Davison","year":"2012","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.eururo.2018.02.026_bib0735","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.juro.2016.08.007","article-title":"Emotional distress increases the likelihood of undergoing surgery among men with localized prostate cancer","volume":"197","author":"Orom","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0740","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jamainternmed.2014.3021","article-title":"Physician variation in management of low-risk prostate cancer: a population-based cohort study","volume":"174","author":"Hoffman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eururo.2018.02.026_bib0745","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jamainternmed.2015.2835","article-title":"Contemporary nationwide patterns of active surveillance use for prostate cancer","volume":"175","author":"Maurice","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eururo.2018.02.026_bib0750","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/cam4.1132","article-title":"Trends in active surveillance for very low-risk prostate cancer: do guidelines influence modern practice?","volume":"6","author":"Parikh","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.eururo.2018.02.026_bib0755","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.juro.2014.01.105","article-title":"Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer","volume":"192","author":"Filson","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0765","doi-asserted-by":"crossref","first-page":"e759","DOI":"10.1016\/j.juro.2015.02.2248","article-title":"Emotional distress predicts choosing surgery over active surveillance in clinically localized prostate cancer patients","volume":"193","author":"Orom","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0770","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/pon.3444","article-title":"\u2018It's not like you just had a heart attack\u2019: decision-making about active surveillance by men with localized prostate cancer","volume":"23","author":"Volk","year":"2014","journal-title":"Psychooncology"},{"key":"10.1016\/j.eururo.2018.02.026_bib0775","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.urology.2010.10.039","article-title":"Factors that influence patient enrollment in active surveillance for low-risk prostate cancer","volume":"77","author":"Gorin","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2018.02.026_bib0780","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12894-017-0225-3","article-title":"Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty","volume":"17","author":"Mader","year":"2017","journal-title":"BMC Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0785","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1353\/nib.2016.0006","article-title":"Is \u201cactive surveillance\u201d an acceptable alternative?.: a qualitative study of couples\u2019 decision making about early-stage, localized prostate cancer","volume":"6","author":"Le","year":"2016","journal-title":"Narrat Inq Bioeth"},{"key":"10.1016\/j.eururo.2018.02.026_bib0790","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.eururo.2016.12.026","article-title":"A systematic approach to discussing active surveillance with patients with low-risk prostate cancer","volume":"71","author":"Ehdaie","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0795","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3122\/jabfm.2012.06.120128","article-title":"Patient perspective on watchful waiting\/active surveillance for localized prostate cancer","volume":"25","author":"Xu","year":"2012","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.eururo.2018.02.026_bib0800","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/pon.3576","article-title":"\u2018What is this active surveillance thing?.\u2019 Men's and partners\u2019 reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option","volume":"23","author":"O\u2019Callaghan","year":"2014","journal-title":"Psychooncology"},{"key":"10.1016\/j.eururo.2018.02.026_bib0805","doi-asserted-by":"crossref","first-page":"e68563","DOI":"10.1371\/journal.pone.0068563","article-title":"Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications","volume":"8","author":"Mishra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.eururo.2018.02.026_bib0810","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12913-015-0729-z","article-title":"Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial","volume":"15","author":"Wade","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.eururo.2018.02.026_bib0815","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1200\/JCO.2012.45.4801","article-title":"Psychological impact of prostate biopsy: physical symptoms, anxiety and depression","volume":"31","author":"Wade","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0820","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1111\/j.1464-410X.2011.10791.x","article-title":"Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance","volume":"110","author":"Goh","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib0825","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.urolonc.2013.09.018","article-title":"Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance","volume":"32","author":"Orom","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0830","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bju.13651","article-title":"Qualitative study on decision-making by prostate cancer physicians during active surveillance","volume":"120","author":"Loeb","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib0835","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0272989X16662841","article-title":"Physician recommendations trump patient preferences in prostate cancer treatment decisions","volume":"37","author":"Scherr","year":"2017","journal-title":"Med Decis Making"},{"key":"10.1016\/j.eururo.2018.02.026_bib0840","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.socscimed.2008.09.050","article-title":"The evolving concept of health literacy","volume":"67","author":"Nutbeam","year":"2008","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.eururo.2018.02.026_bib0845","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2702.2010.03489.x","article-title":"The needs for men undergoing active surveillance (AS) for prostate cancer: results of a focus group study","volume":"20","author":"Kazer","year":"2011","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.eururo.2018.02.026_bib0850","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1557988316657041","article-title":"Cognitive and affective representations of active surveillance as a treatment option for low-risk prostate cancer","volume":"11","author":"Lyons","year":"2017","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.eururo.2018.02.026_bib0855","series-title":"New active surveillance parameters allow for individualised care","author":"Association AU","year":"2009"},{"key":"10.1016\/j.eururo.2018.02.026_bib0860","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.2009.24.2180","article-title":"Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer","volume":"28","author":"Klotz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0865","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/1049732309332692","article-title":"The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer","volume":"19","author":"Oliffe","year":"2009","journal-title":"Qual Health Res"},{"key":"10.1016\/j.eururo.2018.02.026_bib0870","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.eururo.2013.01.009","article-title":"Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance","volume":"64","author":"Bellardita","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0875","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1557988307300467","article-title":"Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland","volume":"2","author":"Hegarty","year":"2008","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.eururo.2018.02.026_bib0880","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/bju.12557","article-title":"Anxiety and health related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre","volume":"113","author":"Wilcox","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib0885","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bju.13099","article-title":"Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance","volume":"117","author":"Parker","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib0890","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/cncr.29370","article-title":"Prospective quality-of-life outcomes for low-risk prostate cancer: active surveillance versus radical prostatectomy","volume":"121","author":"Jeldres","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2018.02.026_bib0895","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1464-410X.2011.10677.x","article-title":"Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial","volume":"109","author":"Vasarainen","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib0900","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1403494812467503","article-title":"Does quality of life of prostate cancer patients differ by stage and treatment?","volume":"41","author":"Vanagas","year":"2013","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.eururo.2018.02.026_bib0905","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s11136-017-1507-7","article-title":"Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer","volume":"26","author":"Venderbos","year":"2017","journal-title":"Qual Life Res"},{"key":"10.1016\/j.eururo.2018.02.026_bib0910","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2018.02.026_bib0915","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.2017.1652","article-title":"Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer","volume":"317","author":"Chen","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2018.02.026_bib0920","doi-asserted-by":"crossref","first-page":"b4817","DOI":"10.1136\/bmj.b4817","article-title":"Quality of life three years after diagnosis of localised prostate cancer: population based cohort study","volume":"339","author":"Smith","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2018.02.026_bib0925","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.juro.2009.12.099","article-title":"Do anxiety and distress increase during active surveillance for low risk prostate cancer?","volume":"183","author":"van den Bergh","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0930","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1464-410X.2007.07009.x","article-title":"Does active surveillance for men with localized prostate cancer carry psychological morbidity?","volume":"100","author":"Burnet","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib0935","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1464-410X.2011.10200.x","article-title":"Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer","volume":"108","author":"Davison","year":"2011","journal-title":"BJU Int"},{"issue":"Suppl 1","key":"10.1016\/j.eururo.2018.02.026_bib0940","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/bju.12765","article-title":"Anxiety in the management of localised prostate cancer by active surveillance","volume":"114","author":"Anderson","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib0945","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/bju.13582","article-title":"Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life","volume":"118","author":"Lane","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib0950","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.bjc.6603057","article-title":"Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up","volume":"94","author":"Korfage","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2018.02.026_bib0955","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ctrv.2014.11.001","article-title":"Wellbeing during active surveillance for localised prostate cancer: a systematic review of psychological morbidity and quality of life","volume":"41","author":"Carter","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.eururo.2018.02.026_bib0960","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1370\/afm.1926","article-title":"Patients\u2019 survival expectations with and without their chosen treatment for prostate cancer","volume":"14","author":"Xu","year":"2016","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.eururo.2018.02.026_bib0965","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ijc.30123","article-title":"Patients\u2019 perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy","volume":"139","author":"Kendel","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2018.02.026_bib0970","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.juro.2007.05.039","article-title":"The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance","volume":"178","author":"Latini","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib0975","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0027-9684(15)30359-X","article-title":"Men's perspectives on selecting their prostate cancer treatment","volume":"103","author":"Xu","year":"2011","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.eururo.2018.02.026_bib0980","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/pon.3657","article-title":"A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels","volume":"24","author":"Venderbos","year":"2015","journal-title":"Psychooncology"},{"key":"10.1016\/j.eururo.2018.02.026_bib0985","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pec.2017.08.022","article-title":"Informational needs during active surveillance for prostate cancer: a qualitative study","volume":"101","author":"Loeb","year":"2018","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.eururo.2018.02.026_bib0995","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40271-014-0066-z","article-title":"Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program","volume":"7","author":"Berger","year":"2014","journal-title":"Patient"},{"key":"10.1016\/j.eururo.2018.02.026_bib1000","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.urology.2012.04.053","article-title":"Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners","volume":"80","author":"Seiler","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2018.02.026_bib1005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00002820-200503000-00003","article-title":"A qualitative analysis of interviews of men with early stage prostate cancer: the Prostate Cancer Lifestyle Trial","volume":"28","author":"Kronenwetter","year":"2005","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.eururo.2018.02.026_bib1010","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-9056(15)60358-X","article-title":"363 Educational seminars increase confidence and decreases dropout from active surveillance","volume":"14","author":"Kinsella","year":"2015","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2018.02.026_bib1015","doi-asserted-by":"crossref","first-page":"e008953","DOI":"10.1136\/bmjopen-2015-008953","article-title":"Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial","volume":"5","author":"Wade","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.eururo.2018.02.026_bib1020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1464-410X.2002.02846.x","article-title":"Is \u2018watchful waiting\u2019 a real choice for men with prostate cancer?. A qualitative study","volume":"90","author":"Chapple","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib1025","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0022-5347(05)64303-0","article-title":"Sociodemographic characteristics and health related quality of life in men attending prostate cancer support groups","volume":"168","author":"Katz","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib1030","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bju.13410","article-title":"Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate Cancer Research International: Active Surveillance (PRIAS) study","volume":"118","author":"Bokhorst","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.02.026_bib1035","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.eururo.2015.06.012","article-title":"Compliance rates with the Prostate Cancer Research International Active Surveillance (PRIAS) protocol and disease reclassification in noncompliers","volume":"68","author":"Bokhorst","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib1040","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/cncr.23028","article-title":"Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer","volume":"110","author":"Sommers","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2018.02.026_bib1045","first-page":"CD001431","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"10","author":"Stacey","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2018.02.026_bib1050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/15412550802093108","article-title":"Motivational interviewing in health care: helping patients change behavior","volume":"5","author":"Rollnick","year":"2008","journal-title":"COPD J Chronic Obstr Pulmon Dis"},{"key":"10.1016\/j.eururo.2018.02.026_bib1055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000126073","article-title":"Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status","volume":"77","author":"Joosten","year":"2008","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.eururo.2018.02.026_bib1060","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.pec.2016.02.003","article-title":"A systematic review of Motivational Interviewing interventions in cancer patients and survivors","volume":"99","author":"Spencer","year":"2016","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.eururo.2018.02.026_bib1065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00002820-200302000-00008","article-title":"Living with untreated localized prostate cancer: a qualitative analysis of patient narratives","volume":"26","author":"Hedestig","year":"2003","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.eururo.2018.02.026_bib1070","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3109\/09638288.2014.996674","article-title":"A systematic review of the effectiveness of stroke self-management programs for improving function and participation outcomes: self-management programs for stroke survivors","volume":"37","author":"Warner","year":"2015","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.eururo.2018.02.026_bib1075","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1258\/jtt.2011.101102","article-title":"Smartphone applications for pain management","volume":"17","author":"Rosser","year":"2011","journal-title":"J Telemed Telecare"},{"key":"10.1016\/j.eururo.2018.02.026_bib1080","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1177\/193229681000400426","article-title":"Evolution of data management tools for managing self-monitoring of blood glucose results: a survey of iPhone applications","volume":"4","author":"Rao","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.eururo.2018.02.026_bib1085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2013.00091","article-title":"Determinants of patient adherence: a review of systematic reviews","volume":"4","author":"Kardas","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.eururo.2018.02.026_bib1090","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3109\/02770903.2016.1155217","article-title":"Enabling and hindering factors influencing adherence to asthma treatment among adolescents: a systematic literature review","volume":"53","author":"Ahmad","year":"2016","journal-title":"J Asthma"},{"key":"10.1016\/j.eururo.2018.02.026_bib1095","first-page":"19","article-title":"Impact of a short-term educational intervention on adherence to asthma treatment and on asthma control","volume":"37","author":"Dalcin Pde","year":"2011","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.eururo.2018.02.026_bib1100","doi-asserted-by":"crossref","first-page":"e007354","DOI":"10.1136\/bmjopen-2014-007354","article-title":"Changing adherence-related beliefs about ICS maintenance treatment for asthma: feasibility study of an intervention delivered by asthma nurse specialists","volume":"5","author":"Chapman","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.eururo.2018.02.026_bib1105","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.pec.2016.11.019","article-title":"Impact of a decision aid on newly diagnosed prostate cancer patients\u2019 understanding of the rationale for active surveillance","volume":"100","author":"Formica","year":"2017","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.eururo.2018.02.026_bib1110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12913-014-0669-z","article-title":"Guideline adherence and health outcomes in diabetes mellitus type 2 patients: a cross-sectional study","volume":"15","author":"Oude Wesselink","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.eururo.2018.02.026_bib1115","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1016\/j.juro.2017.02.1239","article-title":"Worldwide variation in determinants for inclusion and follow-up in active surveillance for low-risk prostate cancer: results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) initiative","volume":"197","author":"Bruinsma","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.02.026_bib1120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.amepre.2010.10.032","article-title":"iPhone apps for smoking cessation: a content analysis","volume":"40","author":"Abroms","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.eururo.2018.02.026_bib1125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0011-393X(03)00002-X","article-title":"A review of the effects of medication delivery systems on treatment adherence in children with asthma","volume":"64","author":"Cohn","year":"2003","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.eururo.2018.02.026_bib1130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1188\/11.ONF.561-568","article-title":"An Internet intervention for management of uncertainty during active surveillance for prostate cancer","volume":"38","author":"Kazer","year":"2011","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.eururo.2018.02.026_bib1135","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.2196\/jmir.2588","article-title":"Diabetes self-management smartphone application for adults with type 1 diabetes: randomized controlled trial","volume":"15","author":"Kirwan","year":"2013","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.eururo.2018.02.026_bib1140","doi-asserted-by":"crossref","first-page":"12812","DOI":"10.18632\/oncotarget.24400","article-title":"Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer","volume":"9","author":"Nowinski","year":"2018","journal-title":"Oncotarget"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818301763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818301763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T21:03:12Z","timestamp":1534280592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283818301763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0302283818301763"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2018.02.026","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2018.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}